REFERENCES
- Akiskal H S. Borderline: an adjective in search of a noun. J Clin Psychiatry. 1985; 46: 41–8. [PUBMED], [INFOTRIEVE]
- Akiskal H S. Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the “borderline” realm. Psychiatr Clin North Am. 1981; 4: 25–46. [PUBMED], [INFOTRIEVE]
- Akiskal H S, Hirschfeld R MA, Yerevanian B I. The relationship of personality to affective disorders. Arch Gen Psychiatry. 1983; 40: 801–10. [PUBMED], [INFOTRIEVE]
- Hyman S. A new beginning for research on borderline personality disorder. Biol Psychiatry. 200251933–5
- Skodol A, Gunderson J G, Pfohl B, Widiger T A, Livesley W J, Siever L J. The borderline diagnosis I: psychophathology, comorbidity, and personality structure. Biol Psychiatry. 2002; 51: 936–50. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lewis G, Appleby L. Personality disorder: the patients psychiatrists dislike. Br J Psychiatry. 1988; 153: 44–9. [PUBMED], [INFOTRIEVE]
- Stern A. Psychoanalytic investigation and therapy in the borderline group of neuroses. Psychoanal Q. 1938; 7: 467–89
- Knight R. Borderline states. Bull Menninger Clin. 1953; 17: 1–12. [PUBMED], [INFOTRIEVE]
- Main T F. The ailment. Br J Med Psychol. 1957; 30: 129–45. [PUBMED], [INFOTRIEVE]
- Kernberg O. Borderline personality organization. J Am Psychoanal Assoc. 1967; 15: 641–85. [PUBMED], [INFOTRIEVE]
- Stone M H. The borderline syndrome: constitution, personality and adaptation. New York, McGraw-Hill. 1980
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., Washington, DC, American Psychiatric Association. 1994
- World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva, WHO. 1992
- Gunderson J G, Singer M T. Defining borderline patients: an overview. Am J Psychiatry. 1975; 132: 1–10. [PUBMED], [INFOTRIEVE]
- Tyrer P. What are the borders of borderline personality disorder?. Acta Psychiatr Scand. 1994; 379: 38–44
- Akiskal H S. Borderline personality or bipolar II? Program and abstracts of the American Psychiatric Association 156th Annual Meeting. May 2003, San Francisco, CA, [Abstract S100A].
- Akiskal H. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol. 1996; 16(suppl 1)4S–14S. [PUBMED], [INFOTRIEVE]
- Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998; 50: 143–51. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Akiskal H S, Bourgeois M L, Angst J, Post R, Moller H, Hirschfeld R.. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000; 59(suppl 1)S5–30. [PUBMED], [INFOTRIEVE]
- Angst J, Gamma A, Bennazzi F, Ajdacic V, Eich D, Rossler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord. 2003; 73: 133–46. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Soares J C, Gershon S.. The diagnostic boundaries of bipolar disorder. Bipolar Disord. 2000; 2: 1–2. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Baldessarini R J. A plea for the integrity of the bipolar disorder concept. Bipolar Disord. 2000; 2: 3–7. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bolton S, Gunderson J G. Distinguishing borderline personality disorder from bipolar disorder: differential diagnosis and implications. Am J Psychiatry. 1996; 153: 1202–7. [PUBMED], [INFOTRIEVE]
- Akiskal H S. The temperamental borders of affective disorders. Acta Psychiatr Scand Suppl. 1994; 379: 32–7. [PUBMED], [INFOTRIEVE]
- Vieta E, Colom F. Personality disorder in bipolar II patients. J Nerv Ment Dis. 1999; 187: 245–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kay J H, Altshuler L L, Ventura J, Mintz J. Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders. Ann Clin Psychiatry. 1999; 11: 187–95. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Brieger P, Ehrt U, Marneros A. Frequency of comorbid personality disorders in bipolar and unipolar affective disorders. Compr Psychiatry. 2003; 44: 28–34. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Carpenter D, Clarkin J F, Glick I D, Wilner P J. Personality pathology among married adults with bipolar disorder. J Affect Disord. 1995; 34: 269–74. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment non-compliance in euthymic bipolar patients. J Clin Psychiatry. 2000; 61: 549–55. [PUBMED], [INFOTRIEVE]
- Bieling P, Mac Queen G M, Marriot M J, Robb J C, Begin H, Joffe R T, et al, Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms. Bipolar Disord. 2003; 5: 14–21. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Pica S, Edwards J, Jackson H J, Bell R C, Bates G W, Rudd R P. Personality disorders in recent-onset bipolar disorder. Compr Psychiatry. 1990; 31: 499–510. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Peselow E D, Sanfilipo M S, Fieve R R. Relationship between hypomania and personality disorders before and after successful treatment. Am J Psychiatry. 1995; 152: 232–8. [PUBMED], [INFOTRIEVE]
- O'Connell R A, Mayo J A, Sciuotto M S. PDQ-R personality disorders in bipolar patients. J Affect Disord. 1991; 23: 217–21. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Loranger A W, Lenzenweger M F, Gartner A F, Susman V L, Herzig J, Zammit G K, et al, Trait-state artifacts and the diagnosis of personality disorders. Arch Gen Psychiatry. 1991; 48: 720–8. [PUBMED], [INFOTRIEVE]
- Judd L L, Akiskal H S, Schletter P J, Coryell W, Endicott J, Maser J D, et al, A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003; 60: 261–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Deltito J, Martin L, Riefkohl J, Austria B, Kissilenko A, Corless P, et al, Does borderline personality disorder belong to the bipolar spectrum?. J Affect Disord. 2001; 67: 221–8. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Perugi G, Akiskal H S, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A, et al, The high prevalence of soft bipolar II features in atypical depression. Compr Psychiatry. 1998; 39: 63–71. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Akiskal H, Walker P, Puzantian V, King D, Rosenthal T L, Dranon M. Bipolar outcome in the course of depressive illness. Phenomenologic, familial and pharmacologic predictors. J Affect Disord. 1983; 5: 115–28
- Perugi G, Toni C, Travierso M C, Akiskal H S. The role of cyclothymia in atypical depresssion: toward a data-based reconceptualization of the borderline–bipolar II connection. J Affect Disord. 2003; 73: 87–98. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Perugi G, Akiskal H S. The soft bipolar spectrum refined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am. 2002; 25: 713–37. [PUBMED], [INFOTRIEVE]
- Akiskal H S, Hantouche E G, Lancrenon S, Bipolar I I. with and without bipolar temperament. ‘dark’ and ‘sunny’ expressions of soft bipolarity. J Affect Disord. 2003; 73: 49–57. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Coid J. An affective syndrome in psychopaths with borderline personality disorder. Br J Psychiatry. 1993; 162: 641–50. [PUBMED], [INFOTRIEVE]
- Grossman R D. Psychopharmacologic treatment of patients with borderline personality disorder. Psychiatr Ann. 2002; 32: 357–70
- Newton-Howes G, Tyrer P. Pharmacotherapy for personality disorders. Expert Opin Pharmacother. 2003; 4: 1643–9. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cowdry R W, Gardener D L. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988; 45: 111–9. [PUBMED], [INFOTRIEVE]
- Kutcher S, Papatheodorou G, Reiter S, Gardner D. The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol. J Psychiatry Neurosci. 1995; 20: 113–8. [PUBMED], [INFOTRIEVE]
- Frankenberg F R, Zanarini M C. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2002; 63: 442–6
- Pinto O C, Akiskal H S. Lamotrigine as a promising approach to borderline personality disorder. J Affect Disord. 1998; 51: 333–43. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Preston G A, Marchant B K, Reimherr F W, Strong R E, Hedges D W. Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord, (in press).
- Nigg J T, Goldsmith H H. Genetics of personality disorders: perspectives from personality and psychopathology research. Psychol Bull. 1994; 115: 346–80. [PUBMED], [INFOTRIEVE]
- Torgersen S, Lygren S, Oien P A, Skre I, Onsad S, Edvardsen J, et al, A twin study of personality disorders. Compr Psychiatry. 2000; 41: 416–25. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Riso L P, Klein D N, Anderson R L, Ouimette P C. A family study of outpatients with borderline personality disorder and no history of mood disorder. J Personal Disord. 2000; 14: 208–17. [PUBMED], [INFOTRIEVE]
- Clark L A, Livesley W J, Morey L. Personality disorder assessment: the challenge of construct validity. J Personal Disord. 1997; 11: 205–31. [PUBMED], [INFOTRIEVE]
- Livesley W J. Suggestions for a framework for an empirically based classification of personality disorder. Can J Psychiatry. 1998; 43: 137–47. [PUBMED], [INFOTRIEVE]
- First M B, Bell C C, Cuthbert B, Krystal J H, Malison R, Offerd D R, et al, Personality disorders and relational disorders: a research agenda for addressing crucial gaps in DSM. Kupfer D J, First M B, Reiger D A. A research agenda for DSM-V. Washington, DC, American Psychiatric Association. 2002; 123–99
- McGuffin P, Thapar A. The genetics of personality disorder. Br J Psychiatry. 1992; 160: 12–23. [PUBMED], [INFOTRIEVE]
- Skodol A E, Siever L J, Livesley W J, Gunderson J G, Pfohl B, Widiger T A. The borderline diagnosis II: biology, genetics and clinical course. Biol Psychiatry. 2002; 51: 951–63. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Sainslow C A, Grilo C M, McGlashan T H. Factor analysis of DSM-III-R borderline personality criteria in psychiatric inpatients. Am J Psychiatry. 2000; 157: 1629–33
- Silverman J M, Pinkham L, Horvath T B, Coccaro E F, Klar H, Schear S, et al, Affective and impulsive pesonality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatry. 1991; 148: 1378–85. [PUBMED], [INFOTRIEVE]
- White C N, Gunderson J G, Zanarini M C, Hudson J I. Family studies of borderline personality disorder: a review. Harv Rev Psychiatry. 2003; 11: 8–19. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Blackwood D H, St Clair D M, Kutcher S P. P300 event-related potential abnormalities in borderline personality disorder. Biol Psychiatry. 1986; 21: 557–60. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kutcher S P, Blackwood D HR, Gaskell D F, Muir W J, St, Clair D M. Auditory P300 does not differentiate borderline personality disorder from schizotypal personality disorder. Biol Psychiatry. 1989; 26: 766–74. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kutcher S P, Blackwood D H, St Clair D, Gaskell D F, Muir W J. Auditory P300 in borderline personality disorder and schizophrenia. Arch Gen Psychiatry. 1987; 44: 645–50. [PUBMED], [INFOTRIEVE]
- Coccaro E F, Siever L J, Klar H M, Maurer G, Cochrane K, Cooper T B, et al, Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989; 46: 587–99. [PUBMED], [INFOTRIEVE]
- New A S, Hazlett E A, Buchsman M S, Goodman M, Reynolds D, Mitropoulou V, et al, Blunted prefrontal cortical FDG-PET response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry, (in press).
- Siever L J, Buchsbaum M S, New A S, Spiegel-Cohen J, Wei C T, Hazlett E, et al, D1-fenfluramine response in impulsive personality disorder assessed with 18F-deoxyglucose positron emission tomography. Neuropsychopharmacol. 1999; 20: 413–23
- Goyer P F, Andreason P J, Semple W E, Clayton A H, King A C, Compton-Toth B A, et al, Positron-emission tomography and personality disorders. Neuropsychopharmacol. 1994; 10: 21–8
- Raine A, Buchsbaum M, LaCasse L. Brain abnormalities in murderers indicated by positron emission tomography. Biol Psychiatry. 1997; 42: 495–508. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Tebartz, van, Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, et al, Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry. 2003; 54: 163–71
- Baumann B, Bogerts B. Neuroanatomical studies on bipolar disorder. Br J Psychiatry. 2001; 178: S120–7
- Henry C, Mitropoulou V, New A S, Koeningsberg H W, Silverman L J. Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. J Psychiatr Res. 2001; 35: 307–12. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Judd L J, Akiskal H S. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003; 73: 123–31. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Steinberg B J, Trestman R L, Mitropolou V, Serby M, Silverman J, Cocarro C, et al, Depressive response to physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacol. 1997; 17: 264–73
- SteinbergB J, TrestmanR L, Siever L J. The cholinergic and noradrenergic neurotransmitter systems and affective instability in borderline personality disorder. Silk K R. Biological and neurobehavioral studies of borderline personality disorder. Washington, DC, American Psychiatric Press. 1994; 41–62